Results 191 to 198 of about 1,470 (198)

Prospective cohort study evaluating efficacy and safety of efgartigimod in Chinese generalized myasthenia gravis patients

Frontiers in Neurology
Jianying Xi, Fan Zeng, Ting Chang
exaly  

Azathioprine/efgartigimod-alfa/rituximab

Reactions Weekly
openaire   +1 more source

Case report: Rapid clinical improvement in acute exacerbation of MuSK-MG with efgartigimod

Frontiers in Immunology
Xiuming Guo
exaly  

Azathioprine/Efgartigimod-alfa/Prednisone

Reactions Weekly
openaire   +1 more source

Efgartigimod for the treatment of Lambert–Eaton syndrome: a case report

Journal of Neurology
Lili Zhang, Yun Chen, Ming Hu, Yuzhong Wang   +3 more
openaire   +2 more sources

Moving beyond immunoglobulin therapy for CIDP with efgartigimod

Nature Reviews Neurology
openaire   +2 more sources

Efgartigimod-alfa/immune-globulin/rituximab

Reactions Weekly
openaire   +1 more source

Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial

Lancet, The
exaly